Concurrent Antiviral and Immunosuppressive Activities of Leflunomide In Vivo
Open Access
- 13 December 2005
- journal article
- Published by Elsevier in American Journal of Transplantation
- Vol. 6 (1) , 69-75
- https://doi.org/10.1111/j.1600-6143.2005.01152.x
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Use of leflunomide in an allogeneic bone marrow transplant recipient with refractory cytomegalovirus infectionBone Marrow Transplantation, 2004
- EXPERIENCES WITH LEFLUNOMIDE IN SOLID ORGAN TRANSPLANTATIONTransplantation, 2002
- IN VIVO ACTIVITY OF LEFLUNOMIDETransplantation, 1999
- Dihydroorotate Dehydrogenase Is a High Affinity Binding Protein for A77 1726 and Mediator of a Range of Biological Effects of the Immunomodulatory CompoundJournal of Biological Chemistry, 1995
- Inhibition of Protein Tyrosine Phosphorylation in T Cells by a Novel Immunosuppressive Agent, LeflunomideJournal of Biological Chemistry, 1995
- LEFLUNOMIDE IN EXPERIMENTAL TRANSPLANTATIONTransplantation, 1994
- Leflunomide (HWA 486), a novel immunomodulating compound for the treatment of autoimmune disorders and reactions leading to transplantation rejectionInflammation Research, 1991
- CMV INFECTION, CLASS II ANTIGEN EXPRESSION, AND HUMAN KIDNEY ALLOGRAFT REJECTIONTransplantation, 1986
- Infection of laboratory rats with a new cytomegalo-like virusArchiv für die gesamte Virusforschung, 1983
- Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.Journal of Histochemistry & Cytochemistry, 1981